Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes (2023 - 2025)

Historic Deferred Taxes for Organogenesis Holdings (ORGO) over the last 3 years, with Q3 2025 value amounting to -$3.8 million.

  • Organogenesis Holdings' Deferred Taxes fell 7456.78% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year change of. This contributed to the annual value of -$10.7 million for FY2024, which is 42373.91% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Deferred Taxes of -$3.8 million as of Q3 2025, which was down 7456.78% from -$1.0 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Deferred Taxes high stood at $3.3 million for Q4 2023, and its period low was -$3.8 million during Q3 2025.
  • Over the past 3 years, Organogenesis Holdings' median Deferred Taxes value was -$1.7 million (recorded in 2024), while the average stood at -$1.3 million.
  • Per our database at Business Quant, Organogenesis Holdings' Deferred Taxes plummeted by 18553.31% in 2024 and then crashed by 7456.78% in 2025.
  • Over the past 3 years, Organogenesis Holdings' Deferred Taxes (Quarter) stood at $3.3 million in 2023, then tumbled by 185.53% to -$2.8 million in 2024, then crashed by 35.49% to -$3.8 million in 2025.
  • Its Deferred Taxes stands at -$3.8 million for Q3 2025, versus -$1.0 million for Q2 2025 and -$1.3 million for Q1 2025.